Aker BioMarine ASA (1PG)
Munich
11.26
0.00 (0.00%)
Closed
Aug 25, 2026
Day's Range
11.2611.26
52 wk Range
6.8911.26
Financial Statements - 1PG - Aker BioMarine ASA
Revenue
218.10M▲ 9.6%
Net Income
-22.80M▼ 112.5%Net Margin -10.5%
EBITDA
32.80M▼ 11.6%
Free Cash Flow
-4.90M▲ 55.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 218.10M | 199M | 196.30M | 277.20M | 262.10M | 288.58M |
| Cost of Goods | 120.30M | 120.60M | 123.80M | 162.40M | 174M | 179.01M |
| Gross Profit | 97.80M | 78.40M | 72.40M | 114.80M | 88.10M | 109.57M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 12.90M | -5.30M | -10.40M | 19.20M | -16.60M | 4.79M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -2.80M | -12.10M | -32.30M | 12.20M | -7.40M | 688K |
| Income Tax | 0 | -100K | 0 | 2.20M | 600K | 6.15M |
| Net Income | -22.80M | 182.60M | -9M | 10M | -8M | -5.46M |
| EPS Basic | - | 2.09 | -0.1 | 0.11 | -0.09 | -0.07 |
| EPS Diluted | - | 2.09 | -0.1 | 0.11 | -0.09 | -0.07 |
| Basic Shares Outstanding | - | 87.68M | 87.66M | 91.86M | 91.82M | 81.83M |
| Diluted Shares Outstanding | - | 87.68M | 87.66M | 91.86M | 91.82M | 81.83M |
| Ebit | 11.10M | -9.60M | -12.60M | 32.50M | 6.30M | 19.42M |
| Ebitda | 32.80M | 37.10M | 39.70M | 75.60M | 56.40M | 66.71M |
| Net Income Continuous Operations | -22.80M | 182.60M | -9M | 10M | -8M | -5.46M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
